Allan KC, Joo JH, Kim S, et al
Rights and permissions Open Access
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, reveals that the medication suppresses signaling in the brains reward center thought to be involved in food noisebut only temporarily
Understanding your injection technique and maintaining proper medication storage remains important throughout the taper
Body weight control emerged as one of the most important outcomes of GLP-1 RAs therapy in SID, a benefit that is rarely achieved with other antihyperglycaemic treatments
Reduced appetite on GLP-1 therapy can lead to dehydration, which can concentrate liver enzymes and affect your results